SI-BONE, Inc. SIBN

Full chart Compare
Set alert

Price alert · SIBN

All alert types
24.88 USD +1.11 (+4.65%)

Nov 4, 2026, 9:46 AM EST

23.88 Day range 25.00
11.48 52-week range 25.00
YTD
+26.14%
1 year
+62.05%
Market cap
1.10B
Revenue (ttm)
213.60M
Profit margin
-6.85%
EPS (ttm)
-0.31
Shares out
44.82M
Forward P/E
-76.66
YTD return
+26.14%
1-year return
+62.05%
Volume
132.76K
Avg volume
620.29K
Open
24.00
Previous close
23.77
Day's range
23.88 – 25.00
52-week range
11.48 – 25.00
Beta
0.62
Analysts
Strong Buy
Price target
25.89 (+4.1%)
Earnings date
Feb 22, 2027

5m +2.14 (+9.89%)

202224Oct 28Oct 29Oct 30Nov 2Nov 323.77

Key statistics

Enterprise value
803.09M
PEG ratio
0.00
Price / sales
4.99
Price / book
5.84
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
15.20%
Free cash flow
-861.88K
Total cash
145.94M
Total debt
42.80M
Return on equity
-8.30%
Short % of float
12.23%
50-day average
19.42
200-day average
16.41

Financials — quick view

All financials
SIBN Revenue — quarterly 56.01M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SIBN Net income — quarterly -4.09M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SIBN EPS — quarterly -0.09
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SIBN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 22, 2027Dec 30, 2026-0.11———
Nov 2, 2026Sep 30, 2026-0.12637-0.08+0.05+36.69%
Aug 3, 2026Jun 30, 2026-0.14946-0.09+0.06+39.78%
May 11, 2026Mar 31, 2026-0.17-0.10+0.07+41.18%
Feb 23, 2026Dec 31, 2025-0.13-0.04+0.09+69.23%
Nov 10, 2025Sep 30, 2025-0.16-0.11+0.05+31.25%

Upgrades / downgrades

SIBN analyst upgrades and downgrades
DateFirmActionFromTo
Nov 3, 2026UBSmainBuyBuy
Nov 3, 2026TD CowenmainBuyBuy
Nov 3, 2026NeedhammainBuyBuy
Oct 14, 2026Truist SecuritiesmainBuyBuy
Aug 4, 2026UBSmainBuyBuy
Aug 4, 2026Truist SecuritiesreitBuyBuy

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
si-bone.com

News

Your note

Sign in to keep a note on SIBN — it syncs with the Stock Master app.

Insider holders

SIBN insider holders
InsiderRelationLatest transactionDateShares held
DAVIS TIMOTHY E JRDirectorStock Award(Grant)Jun 3, 202676,679
DUNN JEFFREY WDirectorSaleSep 30, 202697,130
FRANCIS LAURA A.Chief Executive OfficerSaleOct 11, 20260
FREUND JOHN GORDONDirectorStock Award(Grant)Jun 3, 2026146,025
HILLEMAN JERYL LDirectorStock Award(Grant)Jun 3, 202643,772
HINCKLEY GREGORY KDirectorConversion of Exercise of derivative securityApr 6, 2026180,738

Institution ownership

SIBN institution ownership
Holder% heldSharesValueReported
First Light Asset Management, LLC18.33%8,127,985193.20MJun 29, 2026
Blackrock Inc.8.29%3,676,25987.38MJun 29, 2026
Cadian Capital Management, LP7.55%3,347,57479.57MJun 29, 2026
American Century Companies Inc5.66%2,510,96359.69MJun 29, 2026
Brown Advisory Inc.4.68%2,077,13449.37MJun 29, 2026
Granahan Investment Management LLC4.35%1,931,18245.90MJun 29, 2026

Fund ownership

SIBN fund ownership
Holder% heldSharesValueReported
American Century Mutual Funds, Inc.-Small Cap Growth Fund4.28%1,895,95445.07MJul 30, 2026
IMPAX FUNDS SERIES TRUST I-Impax Small Cap Fund3.21%1,425,01033.87MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.01%1,337,04831.78MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.56%1,136,59427.02MSep 29, 2026
First Eagle Funds-First Eagle Small Cap Opportunity Fund1.52%673,47616.01MJul 30, 2026
College Retirement Equities Fd.-College Retirement Equities Fd. - Tota1.30%578,35413.75MJun 29, 2026